demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 (hospitalized or not)
Immunostimulants drugs
levamisole Roostaei

2 studies excluded by filtering options 1

5450 Pereda, 0 0100selection pending
5565 Pereda, 2020 0130selection pending